Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Clinical and Molecular Models of Prognostication in Mastocytosis: Analysis Based on 580 Consecutive Cases

Animesh Pardanani, MBBS, PhD, Yoseph Elala, MD, Sahrish Shah, MD, Terra L. Lasho, PhD, Mrinal M. Patnaik, MDMBBS, Darci Zblewski, APRN, C-NP, Rhett P. Ketterling, Curtis A. Hanson, MD, Ayalew Tefferi, MD

Blood (2018) 132 (Supplement 1): 582.

https://doi.org/10.1182/blood-2018-99-113914

Published: 2018

Journal Articles

When to Suspect Systemic Mastocytosis?

Sibel Kaplan, MD, Baris Kuskonmaz, MD, özge Ulusoy Soyer, Selin Aytaç, Fatma Gümrük

Blood (2018) 132 (Supplement 1): 5826.

https://doi.org/10.1182/blood-2018-99-119809

Published: 2018

Journal Articles

Preliminary Safety and Clinical Activity in a Phase 1 Study of Blu-285, a Potent, Highly-Selective Inhibitor of KIT D816V in Advanced Systemic Mastocytosis (SM)

Mark W. Drummond, PhD MD, Daniel J. DeAngelo, MD PhD, Michael W. Deininger, MD PhD, Deepti Radia, MBBS, MRCPI, FRCPath MSc, MD, Albert Thomas Quiery, MD, Elizabeth O Hexner, MD, Hongliang Shi, MS, Terri Alvarez-Diez, PhD, Erica K. Evans, PhD, Mary Ellen Healy, MS, Beni B. Wolf, MD PhD, Srdan Verstovsek, MD PhD

Blood (2016) 128 (22): 477.

https://doi.org/10.1182/blood.V128.22.477.477

Published: 2016

Journal Articles

Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis

Blood (2015) 126 (8): 1009–1016.

https://doi.org/10.1182/blood-2014-12-614743

Published: 2015

Includes: Supplemental data

Journal Articles

SF3B1 , a Splicing Factor Gene, Is Infrequently Mutated in Rare Bone Marrow Failure Diseases but Still Associated with Ring Sideroblast Phenotype

Valeria Visconte, PhD, Heesun J. Rogers, MD, PhD, Ali Tabarroki, MD, Edy Hasrouni, Fabiola Traina, MD, PhD, Yang Liu, Christine L. O'Keefe, PhD, Jaroslaw P. Maciejewski, MD, PhD, Mikkael A. Sekeres, MD, MS, Fred H. Hsieh, MD, Ramon V Tiu, MD

Blood (2012) 120 (21): 3485.

https://doi.org/10.1182/blood.V120.21.3485.3485

Published: 2012

Journal Articles

Midostaurin a Multi-Targeted Oral Kinase Inhibitor in Systemic Mastocytosis: Report of An Open-Label Compassionate Use Program in the United Kingdom

Steven Knapper, DM MRCP FRCPath, Jonathan Cullis, Mark W. Drummond, PhD, FRCPath, MB, CHB, Roger Evely, Tamara Everington, Christine Hoyle, Lorna McLintock, MBChB, MD, MRCP, FRCPath, Christopher Poynton, DM, FRCP, FRCPath, Deepti Radia, MD

Blood (2011) 118 (21): 5145.

https://doi.org/10.1182/blood.V118.21.5145.5145

Published: 2011

Journal Articles

Telangiectasia Macularis Eruptiva Perstans: Report of Three Cases

Gizem Tumer, MD, Tiffany Jow, BS, W. Clark Lambert, MD, PhD

Blood (2011) 118 (21): 5176.

https://doi.org/10.1182/blood.V118.21.5176.5176

Published: 2011

Journal Articles

Activity of Dasatinib Against Novel KIT-N822I Mutation In Familial Cutaneous Mastocytosis

Bartosz Wasag, PhD, Marek Niedoszytko, MD, PhD, Anna Piskorz, PhD, Magdalena Lange, MD, PhD, Joanna Renke, MD, PhD, Ewa Jassem, MD, PhD, Maria Debiec-Rychter, MD, PhD, Janusz Limon, MD, PhD

Blood (2010) 116 (21): 4088.

https://doi.org/10.1182/blood.V116.21.4088.4088

Published: 2010

Journal Articles

KIT D816V and JAK2 V617F Point Mutations Are Recurrently Found In Suspected Hypereosinophilic Syndrome

Juliana Popa, MD, Philipp Erben, MD, Georgia Metzgeroth, MD, Georg Bolz, MD, Martin C Mueller, MD, Christoph Walz, MD, Hans Peter Horny, MD, Philipp Ströbel, MD, Alexander Marx, MD, Nicholas C.P. Cross, PhD, FRCPath, Andreas Hochhaus, Wolf-Karsten Hofmann, MD, Andreas Reiter, MD

Blood (2010) 116 (21): 4100.

https://doi.org/10.1182/blood.V116.21.4100.4100

Published: 2010

Journal Articles

Prognostically Relevant Breakdown of 138 Patients with Systemic Mastocytosis Associated with Another Hematological Malignancy

Animesh D. Pardanani, MBBS, PhD, Ken-Hong Lim, Terra L Lasho, MT(ASCP), Christy Finke, BS, Chin Yang Li, MD, Ayalew Tefferi, MD

Blood (2008) 112 (11): 2808.

https://doi.org/10.1182/blood.V112.11.2808.2808

Published: 2008

Journal Articles

Revisiting Mastocytosis in Adults: A Mayo Clinic Case Series of 342 Patients Including Information on KIT D816V and JAK2 V617F.

Ken-Hong Lim, Ayalew Tefferi, MD, Terra L Lasho, MT(ASCP), Christy Finke, BS, Chin Yang Li, MD, Ani mesh D. Pardanani, MBBS, PhD

Blood (2008) 112 (11): 1757.

https://doi.org/10.1182/blood.V112.11.1757.1757

Published: 2008

Journal Articles

Systemic Mastocytosis with Eosinophilia: A Novel Diagnostic Approach To Distinguish Imatinib-Resistant Kit D816V-Associated Mast Cell Disease from Imatinib-Sensitive FIP1L1/PDGFRA-Associated Hypereosinophilic Syndrome.

Todd M. Wilson, Irina Maric, Amy D. Klion, Cem Akin, Melody Carter, Weiming Fu, Jennifer Stoddard, Linda Scott, Arnold Kirshenbaum, Michael Fay, Thomas B. Nutman, Pierre Noel, Dean D. Metcalfe, Jamie Robyn

Blood (2006) 108 (11): 2683.

https://doi.org/10.1182/blood.V108.11.2683.2683

Published: 2006

Journal Articles

Lack of Detection of FIP1L1-PDGFRA Gene Fusion in a Cohort of Mastocytosis with Eosinophilia.

Stephane Barete, Frederic Feger, Eric Delabesse, Olivier Lortholary, Philippe Casassus, Michel Arock, Fabienne Palmerini, Parice Dubreuil, Christian de Gennes, Camille Frances, Elisabeth A. Macintyre, Olivier Hermine

Blood (2005) 106 (11): 4967.

https://doi.org/10.1182/blood.V106.11.4967.4967

Published: 2005

NARROW

Clinical and Molecular Models of Prognostication in Mastocytosis: Analysis Based on 580 Consecutive Cases

When to Suspect Systemic Mastocytosis?

Preliminary Safety and Clinical Activity in a Phase 1 Study of Blu-285, a Potent, Highly-Selective Inhibitor of KIT D816V in Advanced Systemic Mastocytosis (SM)

Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis

SF3B1 , a Splicing Factor Gene, Is Infrequently Mutated in Rare Bone Marrow Failure Diseases but Still Associated with Ring Sideroblast Phenotype

Midostaurin a Multi-Targeted Oral Kinase Inhibitor in Systemic Mastocytosis: Report of An Open-Label Compassionate Use Program in the United Kingdom

Telangiectasia Macularis Eruptiva Perstans: Report of Three Cases

Activity of Dasatinib Against Novel KIT-N822I Mutation In Familial Cutaneous Mastocytosis

KIT D816V and JAK2 V617F Point Mutations Are Recurrently Found In Suspected Hypereosinophilic Syndrome

Prognostically Relevant Breakdown of 138 Patients with Systemic Mastocytosis Associated with Another Hematological Malignancy

Revisiting Mastocytosis in Adults: A Mayo Clinic Case Series of 342 Patients Including Information on KIT D816V and JAK2 V617F.

Systemic Mastocytosis with Eosinophilia: A Novel Diagnostic Approach To Distinguish Imatinib-Resistant Kit D816V-Associated Mast Cell Disease from Imatinib-Sensitive FIP1L1/PDGFRA-Associated Hypereosinophilic Syndrome.

Lack of Detection of FIP1L1-PDGFRA Gene Fusion in a Cohort of Mastocytosis with Eosinophilia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only